SV

Street Verdict

Analyst Scorecard

A record of what S Prabhakar Kudva said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on Pharma for 2025, seeing it as a growth play. The sector is poised for improved fundamentals over the coming quarters, making it an attractive investment opportunity after recent market corrections.”
Nifty PharmaBullishCalled 27 Feb 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee S Prabhakar Kudva’s full track record